Anaphylactoid reaction after the use of sodium tetradecyl sulfate: a case report.

Angiology

Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.

Published: December 2007

Sodium tetradecyl sulfate is a sclerosing agent that has been widely used to treat varicose veins of the legs and digestive tract. Despite the multitude of side-effects of sclerotherapy procedures and sclerosing-drug administration, the medical literature reports only on a few cases of life-threatening hypersensitivity reactions resulting from sodium tetradecyl sulfate therapy. A case is reported of a 49-year-old woman who developed anaphylactoid reaction after the administration of the Fibro-vein for varicose veins in the legs. Attention is drawn to this adverse event and underlines the necessity for potential hypersensitivity assessment before the drug application.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319706291170DOI Listing

Publication Analysis

Top Keywords

sodium tetradecyl
12
tetradecyl sulfate
12
anaphylactoid reaction
8
varicose veins
8
veins legs
8
reaction sodium
4
sulfate case
4
case report
4
report sodium
4
sulfate sclerosing
4

Similar Publications

Vascular malformations (VMs) are congenital abnormalities of blood or lymphatic vessels, present at birth and growing proportionally with the individual. They are classified into types such as capillary, venous, lymphatic, and arteriovenous malformation (AVMs). Symptoms include discoloration, swelling, pain, or functional impairment, depending on the type and location.

View Article and Find Full Text PDF

The oxidation kinetics of phenylalanine (Phe) by Ce(IV) have been examined in both the absence and presence of aqueous micellar media with asymmetric tails, specifically using sodium dodecyl sulfate (SDS) and sodium tetradecyl sulfate (STS) surfactants. The reaction progress was monitored by observing a decrease in absorbance using UV-vis spectroscopy. Interestingly, the kinetic profile revealed a consistent increase in the observed rate constant values as the concentration of the surfactant increased.

View Article and Find Full Text PDF

Diclofenac Removal by Alkylammonium Clay Minerals Prepared over Microwave Heating.

ACS Omega

December 2024

Universidade Federal da Paraíba, Núcleo de Pesquisa e Extensão - Laboratório de Combustíveis e Materiais (NPE - LACOM), Cidade Universitária s/n - Campus I, 58051-900 João Pessoa, PB, Brazil.

Diclofenac is an emerging contaminant widely detected in water and has had adverse effects on the biota. In this study, the adsorbents were prepared by reacting tetradecyl-(C), hexadecyl-(C), and octadecyltrimethylammonium (C) bromides with sodium vermiculite (Na-Ver) and used for the removal of the first time for diclofenac sodium from aqueous solution. Synthesis was carried out in a microwave-assisted reactor operating at 50 °C for 5 min, using proportions of organic salts in 100 and 200% of the phyllosilicate cation exchange capacity.

View Article and Find Full Text PDF

Treatment of hereditary hemorrhagic telangiectasias with sclerotherapy: A case series.

Am J Otolaryngol

December 2024

Department of Otolaryngology - Head and Neck Surgery, Washington University School of Medicine, 660 S Euclid Ave, CB 8115, St. Louis, MO 63110, USA; Clinical Outcomes Research Office, Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, 660 S Euclid Ave, CB 8115, St. Louis, MO 63110, USA. Electronic address:

Background: Hereditary hemorrhagic telangiectasia (HHT) is characterized by abnormal blood vessel formation. One treatment for HHT-related arteriovenous malformations (AVMs) is sclerotherapy, which collapses the blood vessels by irritating the endothelial lining.

Methods: This case series describes two HHT patients undergoing in-office sodium tetradecyl sulfate sclerotherapy for non-nasal telangiectasias and AVMs.

View Article and Find Full Text PDF

Purpose: To propose a standardized method of subjectively and objectively evaluating outcomes of sclerotherapy in treating low flow vascular malformations.

Materials And Methods: Sixty-six patients with low flow vascular malformations (venous, lymphatic, or combined) were treated with percutaneous sclerotherapy using bleomycin, doxycycline, or sodium tetradecyl sulphate. Each lesion required between 2-5 sessions of sclerotherapy with 8-week intervals in between.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!